BUSPIRONE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Buspirone Hydrochloride patents expire, and what generic alternatives are available?
Buspirone Hydrochloride is a drug marketed by Accord Hlthcare, Aiping Pharm Inc, Amneal Pharms Co, Aurobindo Pharma Ltd, Egis, Epic Pharma Llc, Heritage Pharma, Impax Labs Inc, Inventia Hlthcare, Ivax Sub Teva Pharms, Mylan, Nesher Pharms, Oxford Pharms, Rising, Rubicon, Strides Pharma, Teva, Unichem, and Zydus Pharms. and is included in twenty-one NDAs.
The generic ingredient in BUSPIRONE HYDROCHLORIDE is buspirone hydrochloride. There are nineteen drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the buspirone hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Buspirone Hydrochloride
A generic version of BUSPIRONE HYDROCHLORIDE was approved as buspirone hydrochloride by IMPAX LABS INC on March 28th, 2001.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BUSPIRONE HYDROCHLORIDE?
- What are the global sales for BUSPIRONE HYDROCHLORIDE?
- What is Average Wholesale Price for BUSPIRONE HYDROCHLORIDE?
Summary for BUSPIRONE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 19 |
| NDAs: | 21 |
| Finished Product Suppliers / Packagers: | 43 |
| Raw Ingredient (Bulk) Api Vendors: | 111 |
| Clinical Trials: | 75 |
| Patent Applications: | 646 |
| DailyMed Link: | BUSPIRONE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for BUSPIRONE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Johns Hopkins University | Phase 2 |
| University of Oxford | Phase 2 |
| Valenta Pharm JSC | Phase 3 |
Medical Subject Heading (MeSH) Categories for BUSPIRONE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for BUSPIRONE HYDROCHLORIDE
US Patents and Regulatory Information for BUSPIRONE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva | BUSPIRONE HYDROCHLORIDE | buspirone hydrochloride | TABLET;ORAL | 075022-001 | Feb 28, 2002 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Ivax Sub Teva Pharms | BUSPIRONE HYDROCHLORIDE | buspirone hydrochloride | TABLET;ORAL | 075385-002 | Mar 1, 2002 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Impax Labs Inc | BUSPIRONE HYDROCHLORIDE | buspirone hydrochloride | TABLET;ORAL | 074253-001 | Mar 28, 2001 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Mylan | BUSPIRONE HYDROCHLORIDE | buspirone hydrochloride | TABLET;ORAL | 075467-004 | Feb 28, 2002 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Rising | BUSPIRONE HYDROCHLORIDE | buspirone hydrochloride | TABLET;ORAL | 075413-002 | Mar 19, 2002 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Mylan | BUSPIRONE HYDROCHLORIDE | buspirone hydrochloride | TABLET;ORAL | 075467-002 | Mar 28, 2001 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
